Suppr超能文献

肿瘤坏死因子相关凋亡诱导配体和/或白细胞介素-2基因转染的肿瘤浸润淋巴细胞在体外对人肾细胞癌的细胞毒性增强

In vitro enhanced cytotoxicity of tumor-infiltrating lymphocytes transfected with tumor necrosis factor-related apoptosis-inducing ligand and/or interleukin-2 gene in human renal cell carcinoma.

作者信息

Tian Jun-Qiang, Wang Zhi-Ping, Rodriguez Ronald, Fu Jun-Sheng, Lu Jian-Zhong, Ma Bao-Liang

机构信息

Lanzhou University School of Life Science, Lanzhou, GanSu, China.

出版信息

Urology. 2006 May;67(5):1093-8. doi: 10.1016/j.urology.2005.11.030. Epub 2006 Apr 25.

Abstract

OBJECTIVES

To investigate whether tumor-infiltrating lymphocytes (TILs) transfected with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and interleukin-2 (IL-2) genes are capable of improving the potency and efficacy of propagation and cytotoxicity against renal cell carcinoma (RCC) cells in vitro.

METHODS

A mammal expression vector system was constructed. TILs were transfected by liposome-mediated gene transfection. The degree of cytokine mRNA expression was evaluated with Northern blot. Protein expression was determined with Western blot and enzyme-linked immunosorbent assay. Cytotoxicity of TILs against autologous RCC cells and the human RCC cell line (786-0) were examined by chromium release assay. Flow cytometric analyses were performed to determine the apoptosis of tumor cells.

RESULTS

A high level of expression of the human TRAIL and IL-2 stable transfected TILs was observed. The mean IL-2 production was 22.6 +/- 5.2, 507.7 +/- 52.4, and 549.0 +/- 74.0 ng/10(6) cells/24 hours in the TIL/parental, TIL/IL-2, and TIL/TRAIL+IL-2 genes, respectively. The mean cytotoxicity (effector/target ratio 20:1) of TIL/parental, TIL/IL-2, TIL/TRAIL, and TIL/TRAIL+IL-2 against autologous RCC cells in the percentage of cytolysis was 21.2% +/- 4.8%, 32.1% +/- 5.5%, 63.5% +/- 6.6%, and 78.1% +/- 9.63%, respectively. These four groups showed cytotoxic activity against allogeneic 786-0 RCC cells; the corresponding values were 9.8% +/- 3.5%, 12.3% +/- 3.4%, 24.1% +/- 4.9%, and 30.4% +/- 6.2%. The number of apoptotic cells was significantly greater for autologous RCC cells than for 786-0 cells after TIL/TRAIL and TIL/TRAIL+IL-2 treatment.

CONCLUSIONS

TIL/TRAIL+IL-2 and TIL/IL-2 were expanded by autocrine IL-2. TIL/TRAIL+IL-2 and TIL/TRAIL showed significant cytotoxicity that was induced by TRAIL. TILs, including parental TILs and transfected TILs, demonstrated a potent cytotoxicity against RCC cells with remarkable selectivity. Autologous RCC cells seemed more sensitive than allogeneic RCC cells.

摘要

目的

研究转染肿瘤坏死因子相关凋亡诱导配体(TRAIL)和白细胞介素-2(IL-2)基因的肿瘤浸润淋巴细胞(TILs)是否能够提高体外对肾细胞癌(RCC)细胞的增殖能力、效力及细胞毒性。

方法

构建哺乳动物表达载体系统。通过脂质体介导的基因转染法转染TILs。用Northern印迹法评估细胞因子mRNA表达程度。用蛋白质印迹法和酶联免疫吸附测定法测定蛋白质表达。通过铬释放试验检测TILs对自体RCC细胞和人RCC细胞系(786-0)的细胞毒性。进行流式细胞术分析以确定肿瘤细胞的凋亡情况。

结果

观察到转染人TRAIL和IL-2基因的TILs有高水平的稳定表达。在TIL/亲本、TIL/IL-2和TIL/TRAIL+IL-2基因中,IL-2的平均产量分别为22.6±5.2、507.7±52.4和549.0±74.0 ng/10(6)细胞/24小时。TIL/亲本、TIL/IL-2、TIL/TRAIL和TIL/TRAIL+IL-2对自体RCC细胞的平均细胞毒性(效应细胞/靶细胞比例为20:1)在细胞溶解百分比方面分别为21.2%±4.8%、32.1%±5.5%、63.5%±6.6%和78.1%±9.63%。这四组对异基因786-0 RCC细胞均显示出细胞毒性活性;相应的值分别为9.8%±3.5%、12.3%±3.4%、24.1%±4.9%和30.4%±6.2%。在TIL/TRAIL和TIL/TRAIL+IL-2处理后,自体RCC细胞的凋亡细胞数量明显多于786-0细胞。

结论

TIL/TRAIL+IL-2和TIL/IL-2通过自分泌IL-2得以扩增。TIL/TRAIL+IL-2和TIL/TRAIL显示出由TRAIL诱导的显著细胞毒性。包括亲本TILs和转染后的TILs在内的TILs对RCC细胞显示出强大的细胞毒性,且具有显著的选择性。自体RCC细胞似乎比异基因RCC细胞更敏感。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验